Sort
23,748 grants matching “melanoma”
VISTA: A Novel Therapeutic Target That Negatively Regulates Immunity
$300,000Michael Rosenzweig · Immunext, Inc. · R43 · FY2012 · AI
Combination Melanoma Immunotherapy: Antigen Enhancement and Adoptive T Cells
$300,000Estelle Eileen Newton · Cytocure, Llc · R43 · FY2012 · CA
Continuous exosome and oncosome separations using a modified SPLITT system
$300,000Kevin Petersen · Espira, Inc. · N01 · FY2016 · CA
The utility of a mining byproduct, thorium, and a novel radium separation technique to provide full value chain radioisotope supply for Ra224, Ac225, and Pb212 oncology drugs
$300,000Saleem Drera · Radtran Llc · R43 · FY2021 · CA
North Central Cancer Treatment Group
$300,000Jan C Buckner · Mayo Clinic Rochester · U10 · FY2007 · CA
Research Initiation Award: Uncovering the Role of Germline-Specific MAGE-B2 Protein in Maintenance of Cellular Identity
$300,000Steven Damo · Fisk University · · FY2018 · EDU
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
$300,000Frederick Oliver Cope · Navidea Biopharmaceuticals, Inc. · R44 · FY2015 · CA
IGF::OT::IGF DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS
$300,000Hans Keirstead · Lisata Therapeutics Inc · N43 · FY2015 · CA
WP760 for Malignant Melanoma Therapy
$300,000Houston Pharmaceuticals, Inc. · R41 · FY2005 · CA
Cancer Center Support Grant
$300,000Cornelia M Ulrich · University Of Utah · P30 · FY2020 · CA
VISTA: A Novel Therapeutic Target That Negatively Regulates Immunity
$300,000Susan Dana Jones · Immurx Llc · R43 · FY2011 · AI
Synergistic Efficacy of an Interleukin 2 Analog and Antitumor Antigen Antibody
$300,000Ridong Chen · Apt Therapeutics, Inc. · R43 · FY2019 · CA
Anti-inflammatory and Anti-diabetic Therapy for Metabolic Syndrome
$300,000Ridong Chen · Apt Therapeutics, Inc. · R43 · FY2020 · DK
Multimodal Optical Probe for Skin Cancer Detection and Therapy Guidance
$300,000Nicusor Iftimia · Physical Sciences, Inc · R44 · FY2019 · CA
Mimimal-Perturbation Dynamic Control of the Melanoma Gene Regulatory Network
$300,000Dan Schonfeld · University Of Illinois At Chicago · R01 · FY2010 · GM
Development of immuno-PET agents for the selective imaging of CD8 T cells
$300,000Monica Gostissa · Agenus, Inc. · R43 · FY2016 · CA
Recombinant TIL Cell Therapy for Salvage Solid Tumor Patients
$300,000Matthew James Spindler · Gigamune, Inc. · R43 · FY2018 · CA
Receptor-targeted radionuclide therapy combined with immunotherapies to improve metastatic melanoma tumor response.
$300,000Frances L Johnson · Viewpoint Molecular Targeting, Inc. · R43 · FY2019 · CA
Angiogenesis antagonist plus CD40-TLR agonist adjuvant combination vaccine
$300,000Susan Dana Jones · Immurx Llc · R43 · FY2010 · AI
Novel strategy to generate glycan-specific antibodies for cancer immunotherapy
$300,000Brian D. Green · Glycobia, Inc. · R43 · FY2019 · CA
Validation and humanization of a PET imaging agent that targets PD-L1.
$300,000Monica Gostissa · Agenus, Inc. · R43 · FY2016 · CA
Role of CD44 in EC injury and melanoma therapy
$300,000Virginia Commonwealth University · R01 · FY2004 · AI
Fiberoptic Microneedle Device for Combined Light and Nanomedicine Delivery: Mimicking Nature's Design of a Mosquito
$300,000Christopher G Rylander · Virginia Polytechnic Institute And State University · · FY2009 · ENG
Role of CD44 in EC injury and melanoma therapy
$300,000Virginia Commonwealth University · R01 · FY2003 · AI
University of New Mexico Cancer Center Support Grant
$300,000Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2018 · CA